Officiële publicaties MedinCell S.A.

Aandelen

Real Time Euronext Paris Andere beurzen 10:09:43 06-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
14,82 ^EUR	+3,64%		+7,83%	+106,67%

16/04	Medincell gaat een strategische co-ontwikkelings- en licentieovereenkomst aan met AbbVie voor de ontwikkeling van nieuwe generatie langwerkende injecteerbare geneesmiddelen	CI
09/04	Medincell ontvangt $6 miljoen verlengingssubsidie van Unitaid voor proef met malariamedicijn	MT

Changes in management and corporate officers	13/03	CO
Changes in management and corporate officers	13/03	CO
Half-year report	22/12	CO
1st-half-year results	19/12	CO
1st-half-year results	19/12	CO
Monthly statement on voting rights	31-10-23	CO
Monthly statement on voting rights	30-09-23	CO
Minutes of the general assembly	12-09-23	CO
Minutes of the general assembly	12-09-23	CO
Combined general shareholders meeting	04-08-23	CO
Annual ESG Report	28-07-23	CO
Universal registration document	28-07-23	CO
Universal registration document	28-07-23	CO
Monthly statement on voting rights	30-06-23	CO
Annual results	26-06-23	CO
Annual results	26-06-23	CO
Monthly statement on voting rights	31-05-23	CO
Threshold crossings	23-05-23	CO
Corporate officers' Statement : Sale	04-05-23	CO
Monthly statement on voting rights	30-04-23	CO
Monthly statement on voting rights	31-03-23	CO
Threshold crossings	15-03-23	CO
Monthly statement on voting rights	28-02-23	CO
Monthly statement on voting rights	31-01-23	CO
Monthly statement on voting rights	31-12-22	CO